Perakine reductase (PR) is a novel member of the aldo-keto reductase enzyme superfamily from higher plants. PR from the plant Rauvolfia serpentina is involved in the biosynthesis of monoterpenoid indole alkaloids by performing NADPH-dependent reduction of perakine, yielding raucaffrinoline. However, PR can also reduce cinnamic aldehyde and some of its derivatives. After heterologous expression of a triple mutant of PR in Escherichia coli, crystals of the purified and methylated enzyme were obtained by the hanging-drop vapourdiffusion technique at 293 K with 100 mM sodium citrate pH 5.6 and 27% PEG 4000 as precipitant. Crystals belong to space group C222 1 and diffract to 2.0 Å , with unit-cell parameters a = 58.9, b = 93.0, c = 143.4 Å .
Introduction
A rational engineering of the biosynthetic pathways leading to valuable natural products in higher plants is a great scientific challenge and requires deep understanding of the participating enzymes (Kutchan, 1995) . A broad knowledge of such pathways together with biochemical and structural details of the proteins involved is one prerequisite for performing this kind of research. However, biosynthetic knowledge has so far only been accumulated for a few secondary products, in particular examples from the alkaloid field. In this respect, the family of monoterpenoid indole alkaloids, which consists of about 2000 structurally different members, is an important representative. The pathway generating the antiarrhythmic alkaloid ajmaline is the best example from the entire alkaloid family . The pathway has been almost completely elucidated at the enzymatic level and describes a great deal of the Rauvolfia alkaloid metabolism, together with a number of side reactions. Several of the enzymes involved in the biosynthesis of ajmaline have been functionally characterized after overexpression in Escherichia coli or using a recently developed highly effective Nicotiana plant expression system (Marillonnet et al., 2004 (Marillonnet et al., , 2005 Ruppert, Woll et al., 2005) . Heterologous expression gave for the first time quantities of highly purified Rauvolfia proteins suitable for systematic crystallization approaches and elucidation of their threedimensional structures. Strictosidine synthase (STR1), the enzyme generating the biogenetic precursor (strictosidine) of the entire monoterpenoid indole alkaloid family, has recently been crystallized and its X-ray structure has been determined, along with those of complexes with its substrates (Ma et al., 2004 (Ma et al., , 2006 Koepke et al., 2005) . This was the first example from the novel STR1 enzyme family for which the three-dimensional structure has been elucidated (Ma et al., 2006) . A further enzyme, vinorine synthase (VS), located in the middle of the biosynthetic pathway to ajmaline, has also recently been structurally investigated in detail . VS is the first member of the so-called BAHD enzyme superfamily to have its structure determined and may now serve as a structural basis for three-dimensional analyses of other members of this family (D'Auria, 2006). Many enzymes of this particular family are involved in the biosynthesis of clinically important alkaloids such as vinblastine, taxol and morphine (St-Pierre et al., 1998; Walker & Croteau, 2000; Grothe et al., 2001 ). An update on the significance of the BADH enzyme family has recently been reported by D'Auria (2006) . Moreover, the enzyme strictosidine glucosidase (SG), which follows directly after the synthase STR1 in indole alkaloid biosynthesis, has also recently been crystallized and its preliminary X-ray analysis described (Barleben et al., 2005) . SG is one of two glucosidases participating in Rauvolfia alkaloid metabolism. The second is raucaffricine glucosidase (RG), which catalyzes the deglucosylation of raucaffricine (Ruppert et al., 2006) . This hydrolysis leads to the aglycone vomilenine, which on one hand is a direct intermediate in the route to ajmaline (Fig. 1) and on the other hand serves as the precursor of perakine. The aldehydic alkaloid perakine is reduced by an NADPHdependent reductase named perakine reductase (PR). Here, we describe the expression and purification of R. serpentina PR, which is a novel member of the aldo-keto reductase (AKR) enzyme superfamily from higher plants. We also report the crystallization of the methylated enzyme and its preliminary X-ray analysis.
Experimental

Protein expression and purification
In order to obtain sufficient pure PR for crystallization purposes, the PR cDNA (Gene Bank accession No. AY766462) from R. serpentina was cloned into the pQE-2 vector as a fusion protein with an N-terminal 6ÂHis tag. The cDNA was expressed in E. coli strain M15 (Qiagen, Hilden, Germany). Transformed E. coli cells were grown at 310 K in Luria-Bertani medium in 500 ml batches (1000 ml Erlenmeyer flasks) with 50 mg ml À1 ampicillin and 30 mg ml À1 kanamycin. After a cell density of OD 600 ' 0.8 had been reached, expression of PR was induced by adding isopropyl -dgalactopyranoside (IPTG) to a concentration of 0.5 mM. The bacteria were then grown at 298 K for 24 h. M15 cells were harvested by centrifugation (6000g, 8 min, 277 K). The obtained pellet was stored at 253 K if not processed immediately. In a typical experiment for the purification of PR, 10 g of the E. coli pellet was sonicated at 277 K in 50 ml buffer A (50 mM potassium phosphate, 300 mM NaCl pH 8.0) containing 10 mM imidazole and 1 mg ml À1 lysozyme. After centrifugation (14 000g, 30 min, 277 K), the supernatant was applied onto a The biosynthetic pathway in R. serpentina plant cells leading to the antiarrhythmic monoterpenoid indole alkaloid ajmaline through the indolenine intermediate vomilenine is shown. This intermediate can be formed by deglucosylation of the glucoalkaloid raucaffricine, which is catalyzed by raucaffricine glucosidase (RG). In a side-route of the pathway, vomilenine also serves as a precursor of perakine, which is in turn reduced by the NADPH-dependent perakine reductase (PR), producing the alkaloid raucaffrinoline (shown in the dotted box). The conversion of vomilenine into perakine is easily achieved chemically under acidic conditions, but the enzyme catalyzing this reaction has not yet been detected. Other enzymes involved in the pathway and for which three-dimensional structures have recently been analyzed in detail are strictosidine synthase (STR1), strictosidine glucosidase (SG) and vinorine synthase (VS).
5 ml Ni-NTA column. The column was washed with 70 ml buffer A containing 50 mM imidazole, followed by elution of PR with 250 mM imidazole in the same buffer. Enzyme activity was detected after fractionation (into 1 ml fractions) in the first 3-6 ml, which were combined and dialyzed for 12 h against 4 l buffer A pH 7.0 without NaCl but containing 10 mM EDTA.
Enzyme-activity assay
Relative enzyme activity was determined after incubating perakine (or other putative substrates) at 0.2 mM in the presence of 0.2 mM NADPH and 40 mg enzyme at 320 K in buffer B (50 mM potassium phosphate pH 7.0) for 45 min. The product was monitored (peak area) by HPLC. Control experiments were performed in a similar way in the absence of NADPH in order to determine nonspecific substrate binding. The isocratic HPLC solvent system used was 30%:70% acetonitrile:H 2 O (pH 2.3, adjusted with H 3 PO 4 ) on a Lichrospher 60 RP-select B column (250 Â 4 mm, Merck, Darmstadt, Germany) with a flow rate of 1 ml min À1 .
Mutation and methylation of PR
Because of the initial instability of the purified enzyme, we observed severe degradation of the protein within a few days. In order to minimize degradation, the residues Lys98, Lys242 and Lys294 were mutated to Ala by site-directed mutagenesis. The obtained mutant with 24 remaining Lys residues was methylated using the protocol described by Rypniewski et al. (1993) . The reaction with formaldehyde and dimethylamine-borane complex (DMAB) resulted in the dimethylation of the accessible free amino groups of lysine residues and the N-terminal amino group and offers the opportunity to change the surface properties of the protein, increasing the chances of crystallizing the protein. Briefly, 1 ml PR solution (5-10 mg ml
À1
) was mixed with 20 ml DMAB (1 M in water) and 40 ml formaldehyde (1 M in water) was added immediately. After 2 h, the procedure was repeated and the solution was incubated for 15 h after again adding 10 ml DMAB. After adding 100 ml 1 M ammonium sulfate and 2 h incubation, the methylated enzyme solution was dialyzed against 10 mM Tris-HCl and 1 mM dithiothreitol (DTT) pH 7.1. All steps were carried out at 277 K.
Crystallization
Crystallization experiments were carried out by the hanging-drop vapour-diffusion technique using the methylated His-tagged triple mutant. Drops were prepared by mixing 2 ml protein solution (10 mg ml À1 ) with 2 ml reservoir solution and were equilibrated against 1 ml reservoir solution at 293 K. The best crystals were observed when 100 mM sodium citrate pH 5.6 and 27% PEG 4000 was used as precipitant solution. A similar system with additional 0.2 M ammonium acetate and containing 30% PEG 4000 (instead of 99.6 (99.3) † R sym = P hkl P jI i À hIij= P hIi, where I i is the intensity of the ith measurement of reflection hkl and hIi is the average intensity of a reflection. 27%) was previously described for the crystallization of xylose reductase (Kavanagh et al., 2002) . Crystals appeared after 4 d at 293 K and continued to grow for 14 d, reaching maximum dimensions of 0.12 Â 0.12 Â 0.3 mm (Fig. 2) . The unmethylated His-tagged triplemutant protein did not crystallize.
Diffraction data collection and processing
Crystals of methylated PR were cryoprotected in 10% glycerol, 21% PEG 4000, 100 mM sodium citrate pH 5.6 for 30 s and flashcryocooled at 100 K for data collection. Native data were collected to a resolution of 2.0 Å at a wavelength of 0.91841 Å on beamline BL14.2 of BESSY, Berlin, Germany (Table 1 ). The diffraction data were integrated, scaled and merged with XDS (Kabsch, 1993) in the orthorhombic space group C222 1 , with unit-cell parameters a = 58.9, b = 93.0, c = 143.4 Å , = = = 90
. The intensities were then converted to structure-factor amplitudes by the TRUNCATE program from the CCP4 suite (Collaborative Computational Project, Number 4, 1994) . Calculation of the Matthews crystal-packing coefficient (V M = 2.9 Å 3 Da
À1
) suggests the presence of one molecule in the asymmetric unit, with a solvent content of 57.7% (Matthews, 1968) .
Structure solution was attempted by molecular replacement using MOLREP (Vagin & Teplyakov, 1997) as well as Phaser (McCoy et al., 2005) from the CCP4 suite (Collaborative Computational Project, Number 4, 1994) . The structure of the NADPH-dependent family 11 aldo-keto reductase from Bacillis subtilis (PDB code 1pz0; Ehrensberger & Wilson, 2004 ) with 32% sequence identity was used as the search model for molecular replacement. However, a satisfactory solution could not be obtained using molecular replacement.
Results and discussion
Amino-acid sequence alignments of PR (alignment not shown) revealed that the reductase belongs to the widespread AKR superfamily. The highest sequence identities to five members of the family were between 57 and 72%; these were mostly putative enzymes from the plants Arabidopsis, Oryza and Manihot. However, PR is the first example of an AKR to be detected in the group of enzymes involved in alkaloid biosynthesis. PR seems to have a specific function in Rauvolfia alkaloid formation, although it also reduces cinnamic aldehyde and some derivatives, but not ketosteroids such as progesterone. The latter compound is a typical substrate accepted by AKR members (Gavidia et al., 2002) . This raises questions on the probable dual functionality of PR, which may not only include alkaloid biosynthesis but may also include function in phenylpropanoid metabolism, generating cinnamic alcohols (Table 2) . However, more detailed biochemical and structural data are now required in order to explain the precise metabolic role of PR. De novo phasing diffraction experiments on various types of heavy-atom-derivatized PR crystals will be used to determine the structure and to gain a detailed insight into this enzyme of alkaloid metabolism in the Indian medicinal plant Rauvolfia. Table 2 Substrates accepted by the His 6 -tagged perakine reductase mutant.
n.c., no conversion.
Substrate
Relative enzyme activity (%) Perakine 69 AE 1 Cinnamic aldehyde 100 AE 1 p-Coumaric aldehyde 49 AE 1 3-(3,4,5-Trimethoxyphenyl)propenal 42 AE 2 3-[2- 7, dodeca-2,6,10-trienyloxy)phenyl]propenal n.c. Progesterone n.c. Glucose n.c.
